You are here

UK Resilience System Working Group

Primary tabs

Thu, 2013-06-06 02:59 — mdmcdonald

The U.K. Resilience System working group is focused on the development of Resilience Systems in the United Kingdom.

The mission of the U.K. Resilience System working group is to lay the foundations for the development of Resilience Systems, Resilience Networks, and Resilience Health Capacity Zones in the United Kingdom. It will take into account socio-ecological resilience and sustainabilty from the most local level to the national level, including the broader societal system inputs at the global level down to the impacts on institutions and households.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Alexander Fekete	Allan Brimicombe	Hank Rappaport	John Preston	Kathy Gilbeaux	mdmcdonald
Robert Neal	Tristam Riley-Smith

Subscribe to group

Email address for group

uk-resilience-system-working-group@m.resiliencesystem.org

Study indicates mix-and-match Covid vaccine approach boosts immune response

Tue, 2021-06-29 09:26 — mike kraft

Mixing different types of Covid vaccines can boost immune response, study finds Some European countries have started offering alternatives to AstraZeneca as a second shot after the vaccine was linked to rare blood clots. NBC News

A mixed schedule of vaccines where a shot of Pfizer's Covid-19 vaccine is given four weeks after an AstraZeneca shot will produce better immune responses than giving another dose of AstraZeneca, an Oxford study said on Monday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Study indicates mix-and-match Covid vaccine approach boosts immune response
Log in or register to post comments

Trial of first coronavirus variant vaccine, Oxford/AstraZeneca, under way

Mon, 2021-06-28 19:14 — mike kraft

Covid-19 news: Trial of first coronavirus variant vaccine under way The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic Michael Le Page, Clare Wilson, Jessica Hamzelou, Sam Wong, Graham Lawton, Adam Vaughan, Conrad Quilty-Harper and Layal Liverpool New Scientist

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Trial of first coronavirus variant vaccine, Oxford/AstraZeneca, under way
Log in or register to post comments

Oxford vaccine produces strong immune response from booster shot - study

Mon, 2021-06-28 10:03 — mike kraft

Oxford vaccine produces strong immune response from booster shot - study A third shot of the Oxford-AstraZeneca (AZN.L) COVID-19 vaccine produces a strong immune response, researchers said on Monday, adding there was not yet evidence that such shots were needed, especially given shortages in some countries. Alistair Smout Reuters

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Oxford vaccine produces strong immune response from booster shot - study
Log in or register to post comments

New study: Over 2 million in England may have had long COVID

Thu, 2021-06-24 09:11 — mike kraft

Over 2 million in England may have had long COVID, study finds Over 2 million people in England might have had long COVID and suffered one or more COVID-19 symptoms that lasted at least 12 weeks, one of the biggest surveillance studies of the coronavirus found on Thursday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New study: Over 2 million in England may have had long COVID
Log in or register to post comments

Research report on Monoclonal antibodies: They cut risk of dying from COVID-19—but only in some patients

Wed, 2021-06-16 15:02 — mike kraft

Monoclonal antibodies cut risk of dying from COVID-19—but only in some patients Regeneron cocktail reduces mortality by 20% in those who don’t produce antibodies themselves, RECOVERY trial shows Science | AAAS

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Astra antibody cocktail did not prevent COVID-19 symptoms in large trial

Tue, 2021-06-15 10:09 — mike kraft

Astra antibody cocktail fails to prevent COVID-19 symptoms in large trial AstraZeneca (AZN.L) said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines. Vishwadha Chander,Ludwig Burger

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Astra antibody cocktail did not prevent COVID-19 symptoms in large trial
Log in or register to post comments

Countering the Delta variant: Two vaccine doses are highly effective --new study

Mon, 2021-06-14 18:56 — mike kraft

Two doses of vaccine highly effective against Delta variant, U.K. officials say Experts say it's absolutely vital to get the second dose of a two-dose series vaccine. NBC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Countering the Delta variant: Two vaccine doses are highly effective --new study
Log in or register to post comments

British Prime Minister anounces delay in ending coronavirus restrictions

Mon, 2021-06-14 13:29 — mike kraft

Boris Johnson delays end of England’s coronavirus restrictions as delta variant cases climb June 21 was supposed to mark England’s “freedom day,” when the country’s remaining coronavirus restrictions would end, but the government has opted to keep them in place. Jennifer Hassan, Paul Schemm, Adam Taylor Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about British Prime Minister anounces delay in ending coronavirus restrictions
Log in or register to post comments

England’s re-opening into doubt by rapid spread of Delta variant

Fri, 2021-06-11 10:01 — mike kraft

Rapid spread of Delta variant throws England’s re-opening into doubt British Prime Minister Boris Johnson's hopes of ending England's coronavirus lockdown on June 21 hung in the balance on Friday as data showed a further rise in cases of the rapidly spreading Delta variant. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about England’s re-opening into doubt by rapid spread of Delta variant
Log in or register to post comments

Delta variant first identified in India now comprises 91% of new UK cases

Thu, 2021-06-10 12:34 — mike kraft

Variant first identified in India now comprises 91% of new cases in the UK, health minister says The B1.617.2 variant — also called the Delta variant, which was first identified in India — now comprises 91% of new coronavirus cases in the UK according to British Health Minister Matt Hancock. By <a href="/profiles/meg-wagner">Meg Wagner</a>, Melissa Macaya, <a href="/profiles/melissa-mahtani">Melissa Mahtani</a> and <a href="/profiles/veronica-rocha">Veronica Rocha</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Delta variant first identified in India now comprises 91% of new UK cases
Log in or register to post comments

Pages

Page loaded in 0.769 seconds.